Special Ep: A Conversation w the President of Moderna, Dr. Stephen Hoge On Building Back Trust Post-Covid
About this episode
Dr. Stephen Hoge discusses Moderna's innovations and the growing mistrust in mRNA technology and the pharmaceutical industry post-Covid.
Today, we’re joined by Dr. Stephen Hoge, president of Moderna, the biotech company that helped make mRNA a household name during the pandemic, producing a vaccine taken by millions of Americans. Now, Moderna is using that same technology to push into new frontiers, developing treatments for cancers like melanoma and lung cancer. While at the same time, mistrust of mRNA and of the pharmaceutical industry more broadly has only grown. We discuss with Dr. Hoge his company's latest innovations in ...
More episodes of Why Should I Trust You?
- Sunday Special: As Higher Ed Research Falls Short on Impact, Here’s a Fix. A Conversation w Behavioral Scientist Daniel Max Crowley
- The Healthcare Fraud Debate: Are We Actually Mad At the Same Thing? A Convo w Trump/MAHA Supporters + Medicaid Experts
- Why a Health Equity Researcher Says His Field Is A Broken “Industrial Complex”: A Conversation w Dr. Jerel Ezell
- No Episode This Week! We're Taking a Week Off. But Here is Our Full Theme Song!
- Is Our Overuse of Plastics Causing Fertility Issues? A Conversation w Dr. Shanna Swan and Dr. Jasmine McDonald
- A Polling-palooza: Is Health the Driving Issue of These Midterms? A Conversation w Pollsters from KFF, Navigator Research + A MAHA Supporter
Explore listener stats, chart rankings, contacts and more on the Why Should I Trust You? podcast page.